BCAS2 Antibody - Cat. #: CSB-PA594692

SKU: CSB-PA594692

Size :50ul

Clone Number:

Aliases:bcas2 antibody; Breast carcinoma amplified sequence 2 antibody; Breast carcinoma-amplified sequence 2 antibody; DAM 1 antibody; DAM-1 antibody; DAM1 antibody; DNA amplified in mammary carcinoma 1 protein antibody; MGC7712 antibody; Pre mRNA splicing factor SPF27 antibody; Pre-mRNA-splicing factor spf27 antibody; Snt309 antibody; SPF27 antibody; SPF27_HUMAN antibody; Spliceosome associated protein amplified in breast cancer antibody; Spliceosome associated protein SPF 27 antibody; Spliceosome-associated protein SPF 27 antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:O75934

Immunogen:Fusion protein of Human BCAS2

Raised in:Rabbit

Species Reactivity:Human, Mouse

Tested Applications:ELISA, WB, IHC; ELISA:1:1000-1:5000, WB:1:200-1:1000, IHC:1:50-1:200

Background:BCAS2 (breast carcinoma amplified sequence 2), also designated DAM1 (DNA amplified in mammary carcinoma 1 protein) or spliceosome-associated SPF 27, is a ubiquitously expressed nuclear protein that was originally identified as being overexpressed in various breast cancer cell lines. BCAS2 is now known to be a component of the spliceosome, participating in the removal of introns from mRNA precursors. BCAS2 specifically interacts (in a ligand-independent manner) with TR? (thyroid hormone receptor beta), ER (estrogen receptor alpha), ER?, PR (progesterone receptor), and PPAR (Peroxisome proliferator-activated receptor gamma). BCAS2 functions as an ER coactivator and is capable of enhancing ER-mediated transcription. This suggests that BCAS2 is involved in the development of breast cancer.

Clonality:Polyclonal

Isotype:IgG

Purification Method:Antigen affinity purification

Conjugate:Non-conjugated

Buffer:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Form:Liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:BCAS2

Research Areas:Epigenetics and Nuclear Signaling;Tags & Cell Markers